Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Other Non Operating Income: 2018-2025

Historic Other Non Operating Income for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to $149,000.

  • Neurogene's Other Non Operating Income rose 4.20% to $149,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 90.15%. This contributed to the annual value of $574,000 for FY2024, which is 96.49% down from last year.
  • Per Neurogene's latest filing, its Other Non Operating Income stood at $149,000 for Q3 2025, which was down 87.71% from $1.2 million recorded in Q2 2025.
  • Neurogene's Other Non Operating Income's 5-year high stood at $16.4 million during Q4 2023, with a 5-year trough of $143,000 in Q1 2024.
  • In the last 3 years, Neurogene's Other Non Operating Income had a median value of $146,000 in 2024 and averaged $2.3 million.
  • Per our database at Business Quant, Neurogene's Other Non Operating Income crashed by 99.12% in 2024 and then skyrocketed by 741.67% in 2025.
  • Over the past 3 years, Neurogene's Other Non Operating Income (Quarterly) stood at $16.4 million in 2023, then crashed by 99.12% to $144,000 in 2024, then increased by 4.20% to $149,000 in 2025.
  • Its Other Non Operating Income was $149,000 in Q3 2025, compared to $1.2 million in Q2 2025 and $148,000 in Q1 2025.